CHESLEY JONES: Open Payments
NPI 1639693633 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,912 in 103 payments from 13 companies in 2025. Trend: 2023 $1,421 · 2024 $1,443 · 2025 $1,912
Food & beverage: $1,912
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $447 |
| Neurocrine BioSciences, Inc. | 16 | $352 |
| Axsome Therapeutics, Inc. | 13 | $280 |
| Otsuka America Pharmaceutical, Inc. | 10 | $203 |
| Corium, LLC | 11 | $173 |
| Vanda Pharmaceuticals Inc. | 10 | $157 |
| Alkermes, Inc. | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| Lundbeck LLC | 3 | $52 |
| ABBVIE INC. | 3 | $47 |
Products named: CAPLYTA, INGREZZA, Auvelity, Azstarys, REXULTI, ABILIFY ASIMTUFII, FANAPT, HETLIOZ.
Industry payments across KY — which companies pay providers there.
